IRIS UniCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 821
AS - Asia 812
EU - Europa 535
SA - Sud America 207
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 784
SG - Singapore 399
CN - Cina 175
BR - Brasile 155
IT - Italia 123
DE - Germania 87
FR - Francia 82
VN - Vietnam 72
SE - Svezia 62
GB - Regno Unito 39
JP - Giappone 33
IE - Irlanda 30
FI - Finlandia 29
ID - Indonesia 28
CA - Canada 23
KR - Corea 23
IN - India 22
AR - Argentina 21
PL - Polonia 15
UA - Ucraina 15
BD - Bangladesh 12
CO - Colombia 11
HK - Hong Kong 11
RU - Federazione Russa 11
EC - Ecuador 10
ES - Italia 8
MX - Messico 8
NL - Olanda 8
BE - Belgio 6
AT - Austria 5
IQ - Iraq 5
PK - Pakistan 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
MA - Marocco 4
TR - Turchia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
VE - Venezuela 3
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GY - Guiana 1
JO - Giordania 1
LI - Liechtenstein 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.400
Salva come PNG Salva come JPEG
Città #
Singapore 240
San Jose 112
Chandler 97
Ashburn 78
Hefei 45
New York 43
Beijing 41
Los Angeles 32
Tokyo 32
Frankfurt am Main 29
Dublin 28
The Dalles 27
Ho Chi Minh City 26
Milan 24
Munich 23
Jakarta 22
Seoul 22
Council Bluffs 21
Lauterbourg 20
Paris 17
Rome 16
Hanoi 13
Helsinki 13
Marseille 13
Hong Kong 11
Kent 11
Nuremberg 11
São Paulo 11
Warsaw 11
Boston 10
Brooklyn 10
Bogotá 8
Chicago 8
Houston 8
Montreal 8
Pune 8
Turku 8
Jacksonville 7
North Bergen 7
Princeton 7
Boardman 6
Brussels 6
London 6
Orem 6
Seattle 6
Toronto 6
Chennai 5
Curitiba 5
Fairfield 5
Lappeenranta 5
Poplar 5
Portsmouth 5
Santa Clara 5
Appignano 4
Baghdad 4
Brasília 4
Dhaka 4
Guarulhos 4
Madrid 4
Moscow 4
Quito 4
Redwood City 4
Rio de Janeiro 4
Stockholm 4
Wilmington 4
Albiate 3
Ann Arbor 3
Belo Horizonte 3
Biên Hòa 3
Buenos Aires 3
Buffalo 3
Cairo 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Düsseldorf 3
Florence 3
Hyderabad 3
Johannesburg 3
Lahore 3
Manaus 3
Monte Argentario 3
Phoenix 3
Ribeirão Preto 3
San Diego 3
San Francisco 3
San Mateo 3
Tashkent 3
Verona 3
Washington 3
Addis Ababa 2
Algiers 2
Amsterdam 2
Atlanta 2
Bari 2
Bexley 2
Bremen 2
Brno 2
Busto Arsizio 2
Bắc Giang 2
Totale 1.392
Salva come PNG Salva come JPEG
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 156
Effect of moderate and heavy alcohol consumption on intestinal transit time 132
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 124
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 121
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
Microbiota Composition in Diverticular Disease: Implications for Therapy 118
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 109
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 103
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 102
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 99
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 98
Microbiota Composition in Diverticular Disease: Implications for Therapy 97
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 94
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 88
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 86
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 84
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 84
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 83
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 77
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 72
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 71
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 63
Response to Jackson et al 59
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 57
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 55
Totale 2.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 3 1
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025557 13 10 45 20 46 13 21 19 46 77 139 108
2025/20261.239 201 54 108 194 211 56 175 48 69 105 18 0
Totale 2.444